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Original Article
Abstract
Context: Asymptomatic bacteriuria (ASB) in pregnancy is a major risk factor for developing acute cystitis and 
pyelonephritis, especially, among women with sickle cell disease. This study compared the prevalence, pattern, and 
microbiological characteristics of ASB in pregnancy between sickle cell trait (HbAS) and normal hemoglobin AA (HbAA)  
genotype subjects.
Materials and Methods: Culture and sensitivity of mid-stream urine samples were collected from 300 HbAS women 
and 300 matched HbAA control at the antenatal clinic of University of Nigeria Teaching Hospital Enugu, Nigeria from 
August 2010 to December 2011. Analysis was both descriptive and inferential at 95% confidence levels.
Results: Prevalence of ASB in HbAS and HbAA women were 32.7% (98/300) and 32% (96/300) respectively (odd ratio 
(OR) =1.03 [95% confidence interval (CI) 0.73, 1.45]). Escherichia coli was the most common organism isolated in both 
the HbAS group (56.1%, 55/98) and control group (61.4%, 59/96), (OR = 0.80 [95% CI 0.45, 1.42]). The antibiotics with 
the highest microbial sensitivity were ciprofloxacin 90.8% (89/98) and gentamicin 100% (98/98) for HbAS and HbAA 
women respectively.
Conclusions: The prevalence of ASB in pregnant women with HbAS in Enugu, Nigeria was high and did not vary 
significantly from that of woman with HbAA. Therefore, pregnant women irrespective of their sickle cell status would 
benefit from routine screening for ASB.
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Introduction
Pregnant women with sickle cell trait (HbAS) are 
thought to have a greater propensity for the development 
of asymptomatic bacteriuria (ASB), acute cystitis and 
pyelonephritis than pregnant women with normal 
hemoglobin AA (HbAA) genotype.[1] The term asymptomatic 
bacteriuria (ASB) refers to the presence of a positive urine 
culture in an individual in the absence of clinical signs and 
symptoms of urinary tract infection.[2] The diagnosis of this 
condition requires voided urine specimens and isolation of 
at least 105 colony forming units per milliliter of the same 
bacterial strain.[3] It has been shown that pregnancy does not 
increase the risk of ASB,[4] rather it enhances its progression 
to symptomatic disease;[5] therefore, ASB in pregnancy is a 
major risk factor for developing symptomatic urinary tract 
infection during pregnancy.[6] This complication is more 
common in pregnancy because of the relative obstruction by 
the gravid uterus and the dilatory effect of progesterone on 
the urinary collecting tracts;[4] thus, leading to multiplication 
and ascending of the bacteria to the upper urinary tract. 
Furthermore, although the HbAS is often considered to 
be benign, conditions such as hypoxia, hyperviscosity, 
dehydration, and acidosis may enhance sickling of red blood 
cells.[7] This increases the risk of vaso‑occlusion particularly 
in the kidneys, where the relatively anoxic, acidotic and 
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hypertonic milieu favor hemoglobin S polymerization and 
hemolysis as evidenced by elevated lactate dehydrogenase 
levels in the blood of such patients.[7] Furthermore, serum 
free iron released from sickle erythrocytes in the circulation 
leads to the accumulation of free iron in the urine increasing 
the risk of infection.[7] It is obvious therefore that maternal 
bacteriuria may be associated with increased maternal 
and fetal morbidity, and this risk may be higher for HbAS 
pregnant women. This study compared the prevalence of 
ASB, the pattern of bacterial agents and their antimicrobial 
susceptibility between pregnant women with HbAS and 
their HbAA counterpart.
Materials and Methods
This is a cross‑sectional analytical study of two cohorts of 
consenting singleton pregnant women at the University of 
Nigeria Teaching Hospital (UNTH), Enugu, Nigeria, and 
Mother of Christ Specialist Hospital, Enugu, from August 
2010 to December 2011. The study group was made of 
300 consecutive women with HbAS while the control 
group comprised of 300 women with HbAA matched for 
age, parity, and gestational age groups. After recruiting 
an eligible woman for the study group, the next antenatal 
attendee with HbAA who matched the selected participants 
was recruited as the control. Exclusion criteria included 
sickle cell anemia, history of diabetes mellitus, symptoms of 
urinary tract infections or renal disease, history of antibiotics 
use or urethral catheterization within 2 weeks prior to the 
study. Hemoglobin electrophoresis was used for the sickle 
cell genotyping of pregnant women. Ethical approval for 
this study was obtained from the Health Research Ethics 
Committee of UNTH Enugu.
Following informed consent, each study participant was 
educated on how to collect a urine sample. Clean‑catch 
midstream urine sample from each participant was collected 
into a sterile boric acid universal bottles after antero‑posterior 
swabbing of the vulva using sterile gauze soaked in normal 
saline.[5,8,9] Each sample collection was supervised by one 
of the three nurses trained for the procedure. The urine 
samples were sent to the microbiology laboratory within 
one hour of collection. Each urine sample was thoroughly 
mixed by gentle shaking; afterward, a loop‑full (using a 
standard wire loop) was streaked onto Blood agar, Cysteine 
Lactose Electrolyte Deficient medium and MacConkey 
Agar, and incubated aerobically at 37°C for 24 h.[9] Counts 
of 105 organisms or more per milliliter of the urine samples 
were considered significant.[3] Such colonies were identified 
using standard methods thus: Colonial morphology, Gram 
reactions, sugar fermentation, catalase test, coagulase 
test, arginine deaminase test, oxidase test, indole, and 
urea hydrolysis test.[9,10] Sensitivity was determined using 
Kirby‑Bauer disc diffusion technique.[11] The data obtained 
was analyzed by descriptive and inferential statistics using 
SPSS computer software version 16.0. Proportions were 
compared with Chi‑square test and a P value of < 0.05 was 
considered statistically significant.
Participants’ social classes were determined using their 
education status and their husbands’ occupation.[12]
Enugu State is located in the South‑East geo‑political 
zone of Nigeria and it has a population of over 3 million.[13] 
A study among students in the state showed a HbAS 
prevalence of 11%.[14]
The UNTH Enugu is a teaching hospital owned by the 
Federal Government of Nigeria. The average antenatal 
attendance (first visits and revisits) of the hospital is 795 
women/month. On the other hand, the Mother of Christ 
Specialist Hospital, Enugu is a faith based specialist hospital 
located in the capital city of Enugu State. Its average 
antenatal attendance is 703 women/month.
Results
The age range of the study and control groups was 
15‑49 years with a mean of 28.7 ± 5.0 years and 
27.9 ± 4.8 years respectively (P = 0.765). The modal age 
group for both groups was 25‑29 years.
Ninety eight urine samples from the study group showed 
significant culture as against 96 urine samples from the 
HbAA group, which gave ASB prevalence of 32.7% 
and 32.0% respectively. The observed difference was 
not statistically significant (odd ratio (OR) =1.03 [95% 
confidence interval (CI) 0.73, 1.45]).
Seven different types of bacteria were identified during 
the study; 4 (57.1%) out of these were isolated at varying 
proportions from both the HbAS and HbAA groups 
while the remaining 3 (42.9%) were isolated only from 
the urine samples from the control group [Table 1]. 
Table 1: Distribution of organisms isolated in the case 
and control groups





Escherichia coli 55 (56.1) 59 (61.4) 0.47 0.80 (0.45, 1.42)
Staphylococcus 
aureus
33 (33.7) 25 (26.0) 0.27 1.44 (0.78, 2.68)
Klebsiella 6 (6.1) 2 (2.1) 0.28 3.07 (0.60, 15.58)
Enterobacter 4 (4.1) 2 (2.1) 0.68 2.0 (0.36, 11.18)
Citrobacter 0 (0.0) 4 (4.2) 0.06 -
Streptoccocus 
faecalis
0 (0.0) 2 (2.1) 0.24 -
Salmonella 0 (0.0) 2 (2.1) 0.24 -
Total 98 (100.0) 96 (100.0) - -
HbAS=Sickle cell trait; HbAA=Hemoglobin AA
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Furthermore, Escherichia coli was the most common 
organism isolated in both the HbAS group (56.1%, 55/98) 
and control group (61.4%, 59/96); but the difference was 
not significant (OR = 0.80 [95% CI 0.45, 1.42]). Details 
of the distribution of bacterial isolates in the two groups 
are shown in Table 1. The antibiotics with the highest 
microbial sensitivity were ciprofloxacin (90.8%, 89/98) and 
gentamicin (100.0%, 98/98) for HbAS and HbAA groups 
respectively. On the other hand, ampiclox (2.0%, 1/98) and 
amoxicillin (2.1%, 2/96) had the least microbial sensitivity 
for the study and control groups respectively. Details of the 
antibiotics’ microbial sensitivity are shown in Tables 2 and 3.
When participants were stratif ied according to 
socio‑economic class [Table 4], significant differences in 
the prevalence of ASB were observed between the HBAS 
group and the control group, in class 1 (28.2% vs. 55.2%, 
OR = 0.32 [95% CI 0.16, 0.64]); and class 4 (37.9% vs. 
20.7%, OR = 2.34 [1.04, 5.24]). For the remaining social 
classes, the prevalence of ASB did not vary significantly 
between the two groups [Table 4].
Discussion
The modal age group of study participants was 25‑29 years, 
which may suggest that it is the most reproductive age group 
for the pregnant women with HbAS in the study area. 
Previous reports on ASB in pregnancy noted wide variation 
of the prevalence ranging from 7% to 86.6%,[2,5,6,9,15‑23] 
therefore, the prevalence of 32% found in this study may not 
be unexpected. The ASB prevalence in this study is lower 
than the findings from a related study by Thurman et al. in 
United States of America, which showed the prevalence of 
47.5% and 46.9% among HbAS and HbAA respectively.[1] 
As in this study, the proportion of women with ASB was 
higher among the HbAS group when compared to the 
HbAA group, but the difference was not significant.[1] 
However, these two study findings did not support the 
Table 2: Antibiotic sensitivity pattern of organism isolated from cases (HbAS)












Ciprofloxacin 54 28 6 4 92 93.9
Gentamicin 55 32 0 2 89 90.8
Chloramphenicol 42 0 6 2 50 51.0
Nitrofurantoin 28 4 0 0 32 32.7
Ofloxacin 8 24 0 0 32 32.7
Tetracycline 14 4 0 2 20 20.4
Cephalexin 8 10 0 0 18 18.4
Erythromycin 10 5 0 0 15 15.3
Cotrimoxazole 8 4 0 2 14 14.3
Ampicillin 2 0 6 4 12 12.2
Augmentin 0 8 0 0 8 8.2
Amoxycillin 0 6 0 0 6 6.1
Ceftriazone 0 6 0 0 6 6.1
Ampiclox 0 1 0 0 1 1.0
HbAS=Sickle cell trait, Key: “0”=Resistant organism



















Gentamicin 59 25 2 2 4 2 2 96 100.0
Ciprofloxacin 52 22 2 2 4 2 2 86 89.6
Chloramphenicol 44 0 0 2 2 0 2 50 52.1
Nitrofurantoin 38 0 0 2 0 0 0 40 41.7
Ofloxacin 2 16 0 0 0 0 0 18 18.8
Cotrimoxazole 12 4 0 0 0 0 0 16 16.7
Cefuroxime 13 13 0 0 0 2 0 15 15.6
Erythromycin 2 12 0 0 0 0 0 14 14.6
Tetracycline 10 0 0 0 0 2 0 12 12.5
Cephalexin 2 10 0 0 0 0 0 12 12.5
Ampicillin 6 0 0 0 2 0 2 10 10.4
Augmentin 0 8 0 0 0 0 0 8 8.3
Amoxycillin 0 2 0 0 0 0 0 2 2.1
Key: “0”=Resistant organism, HbAA=Hemoglobin AA
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report of a systematic review on hemoglobinopathy, which 
showed that the risk of bacteriuria was higher among 
pregnant women with hemoglobinopathies.[24] Furthermore, 
an earlier study had identified a lower ASB prevalence for 
the HbAS when compared with HbAA women (13.0% 
vs. 9.0%) and in this case, the observed difference was 
statistically significant.[25] This report was supported by a 
more recent study which showed that the prevalence of 
ASB among pregnant women with HbAS were significantly 
higher than that of HbAA women (13.9 vs. 10.8).[26] A 
critical review showed these two studies actually influenced 
the conclusion of the systematic review with respect to 
bacteriuria. Previous studies on ASB in pregnancy had 
shown a trend towards higher prevalence of ASB among 
women from lower socioeconomic classes;[8,15‑18] this trend 
seemed to be the case among HbAS women in this study, 
but the pattern within the HbAA group was not definite. 
Furthermore, though this study showed that the prevalence 
of ASB did not vary between HbAS and HbAA women in 
general, appreciable differences seem to exist within the 
socio‑economic classes [Table 4] for instance, within the 
socio‑economic class one, pregnant women with ASB were 
about 3 times more likely to be HbAA when compared with 
HbAS women; conversely, women in class 4 who had ASB 
were about 2 times more likely to be HbAS than HbAA. 
Further studies are required to study the actual effect of 
socioeconomic status on ASB in pregnancy. Likewise, 
subsequent studies on the relationship between HbAS 
and ASB should control for socio‑economic status. As 
expected, E. coli was the most common organism isolate 
from both study and control groups in this study. This 
finding is in keeping with the reports of previous studies on 
the subject,[1,5,8,17,18,20,21] except the study from Jos, Nigeria 
which recorded Staphylococcus aureus as the most common 
organism while E. coli was not isolated.[9] Furthermore, this 
study did not identify any statistical difference between 
the frequencies of E. coli isolated in both groups which is 
probably because E. coli is a fecal flora in human that also 
colonizes the periurethral area, thereby causing an ascending 
infection of the urinary tract.[27] In the decreasing order of 
frequency, the other organisms isolated from both groups 
included S. aureus, Klebsiella spp., and Enterobacter. Similar 
organisms and those of the same families were isolated in 
previous studies.[1,5,6,16,18,22] This study suggests that ASB 
in HbAS women were less likely to be due to E. coli when 
compared to ASB in HbAA women [Table 1]. On the other 
hand, the odds of ASB in HbAS women due to S. aureus, 
was higher than that of HbAA women, though the observed 
difference was not significant. The microorganism pattern 
observed in this study will help in the determination of 
effective antibiotics for ASB prophylaxis among pregnant 
women.
It is not clear why Citrobacter, Streptococcus faecalis and 
Salmonella spp. were isolated in the HbAA group only; 
a larger sample sized study may help confirm whether 
HbAS is protective against these organisms. Furthermore, 
bacteria isolated in both groups of this study were most 
sensitive to gentamicin and ciprofloxacin, but least sensitive 
to amoxycilin [Tables 3 and 4]. However, the observed 
sensitivity pattern in this study is at variance with the 
findings of earlier reports from the study area;[5,18] for 
instance, Ezeome et al. reported least microbial sensitivity to 
Ciprofloxacin among other drugs.[5] This change in pattern 
underscores the need for continuous monitoring of bacterial 
sensitivity pattern in our environment where antibiotics 
are procured freely over the counter. Unfortunately, the 
antibiotics to which the organisms isolated in this study 
were most sensitive to, fall into the category C of the 
United States Food and Drug Administration classification 
of antibiotics for the treatment of pregnant women with 
ASB.[28]
It is concluded that the prevalence of ASB among pregnant 
women in Enugu, Nigeria is high. Furthermore, pregnant 
women with HbAS do not have higher odds of developing 
ASB when compared to their counterparts with normal 
hemoglobin. Therefore, considering the known effects of 
ASB on pregnancy outcome, there is the need to initiate 
routine screening and treatment of ASB among pregnant 
women in the study area.
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